Donald Trump on Tuesday aimed to borrow for the rapid development of corona virus vaccines, raising concerns about the supply and deadline for vaccinating Americans, and exposing the government for failing to lock in the possibility of purchasing millions of additional doses. Leading competitors. That decision will delay the delivery of the second batch until Pfizer fulfills other international agreements. The revelation, confirmed by those familiar with the matter, came ahead of Trump’s plans to hold a White House summit to celebrate. Regulatory approval of the first vaccine for emergency use in the United States is expected later this week. The news came as the first person in the world to receive a corona virus vaccine since regulatory approval, 90 years after the clinical trials. An elderly woman in the UK who was vaccinated on Tuesday. This is because the United States is set to surpass 15 million corona virus cases, p. Week of nearly 16,000 Americans killed as a result of Govt-19, the world’s highest total. The Trump administration is seeking to allay public suspicions about the vaccine and preserve a key element in the president’s legacy. The administration has plans to distribute and administer the vaccine to be focused on, but officials from President-elect Joe Biden’s alternative committee, which will oversee much of the country’s largest vaccination program in office when he takes office on January 20, have not been invited. Pfizer’s vaccine is expected to be approved by the U.S. Food and Drug Administration (FDA) regulatory panel soon this week, providing 100 million doses – enough for 50 million Americans, as two shots per person is needed for optimal immunity – in the coming months. Under its deal with Pfizer, the Trump administration initially promised to buy 100 million doses, with the option of buying five times as much. This summer, according to a report in the New York Times, he wanted the White House not to lock in an additional 100 million doses for delivery in the second quarter of 2021 because of the support of others who spoke to the Associated Press about the anonymity. It is not authorized to discuss this publicly. A few days before the expected approval of the vaccine, the administration is changing course, but it is not clear whether Pfizer, which has promised other countries, will be able to meet the latest demand at the same time. Deadline. The Pfizer vaccine is one of two on the road to emergency FDA accreditation this month, and the other comes from drug maker Modernna. The Trump administration insisted late Monday that, between those two vaccines and others, the United States could accommodate Americans who want to be vaccinated by the end of the second quarter of 2021. Management told Health Secretary Alex Azhar NBC: “We continue to work to expand across manufacturers. The “Operation Warp Speed” summit will feature Trump, Vice President Mike Pence and a number of government experts. , State leaders and business executives appear to be explaining to the White House that the vaccine is safe and devising management plans to bring it to the American people. Senior executives provided details about the summit on Monday. An official with the Biden change confirmed that no call had been extended. According to people familiar with the matter, officials from the pharmaceutical companies that make the vaccines were not expected to attend, despite receiving invitations. Some expressed concern about the event that contributed to the politicization of the event, further undermining the vaccine development process and public confidence in drugs. According to an official who previewed the event, Trump is about to kick off the event with hints aimed at “celebrating” vaccine development. Trump will sign an executive order prioritizing Americans for corona virus vaccines purchased by the federal government. A second official said the U.S. government would block the supply of the quantities to other countries.
Source